Hochschulschrift
Characterization, optimization & long-term stability of preserved dermal nanostructured lipid carriers (NLC)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
21 cm
- Extent
-
VII, 157 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen
Freie Universität Berlin, Dissertation, 2015
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:56 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Nanosuspensions and nanostructured lipid carriers for dermal application
Nanostructured Lipid Carriers (NLC) in dermal and personal care formulations
Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
Nanostructured lipid carrier (NLC) formulations for topical application
Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours
Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering
Ultra-small nanostructured lipid carriers (usNLC) loaded with coenzyme Q10
Hibiscus sabdariffa-loaded nanostructured lipid carriers (NLC) for fortified nutraceutical milks
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis
Nanosuspensions and nanostructured lipid carriers for dermal application
Nanostructured Lipid Carriers (NLC) in dermal and personal care formulations
Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
Nanostructured lipid carrier (NLC) formulations for topical application
Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours
Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering
Ultra-small nanostructured lipid carriers (usNLC) loaded with coenzyme Q10
Hibiscus sabdariffa-loaded nanostructured lipid carriers (NLC) for fortified nutraceutical milks
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis
Nanosuspensions and nanostructured lipid carriers for dermal application
Nanostructured Lipid Carriers (NLC) in dermal and personal care formulations
Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy
Nanostructured lipid carrier (NLC) formulations for topical application
Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours
Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering
Ultra-small nanostructured lipid carriers (usNLC) loaded with coenzyme Q10
Hibiscus sabdariffa-loaded nanostructured lipid carriers (NLC) for fortified nutraceutical milks
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor